SCHEMBL6638191

SCHEMBL6638191

CCOC(=O)c1ccc(OCC(F)(F)C(F)(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
ESR1 P03372 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
ESR2 Q92731 1/20 0.51
CA14 Q9ULX7 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
LMNA P02545 3/20 0.50
PDK1 Q15118 1/20 0.50
PDK2 Q15119 1/20 0.50
PDK3 Q15120 1/20 0.50
PDK4 Q16654 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6638147 0.88 NPC1 (0.66) NPC1RAB9ASMN1; SMN2CA12CA1
SCHEMBL25360965 0.87 PDK1 (0.52) NPC1RAB9ASMN1; SMN2CA12CA1
SCHEMBL11505972 0.83 CA12 (0.56) NPC1RAB9ASMN1; SMN2CA12CA1
SCHEMBL6634317 0.82 KMT2A (0.50) NPC1RAB9ASMN1; SMN2CA12CA1
SCHEMBL22639615 0.82 PRSS1 (0.49) NPC1SMN1; SMN2LMNACYP1A2MEN1
SCHEMBL15670153 0.80 CYP1A2 (0.42) NPC1RAB9ASMN1; SMN2LMNACYP1A2
SCHEMBL76052 0.80 ALDH1A1 (0.66) NPC1CA12CA1CA2ESR1
SCHEMBL21008649 0.80 CA12 (0.48) NPC1RAB9ASMN1; SMN2CA12CA1
SCHEMBL2721728 0.79 CA12 (0.59) SMN1; SMN2CA12CA1CA2ESR1
SCHEMBL9578562 0.79 PKM (0.53) NPC1RAB9ASMN1; SMN2L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0866793-B1 NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF CHIRON CORP (US) 2004-10-27 EP disclosed
US-6087358-A BACTERICIDES TREATING PATHOGENIC INFECTIONS OF MYCOBACTERIA, CLOSTRIDIUM, CRYPTOSPORIDIUM OR HELICOBACTER AND MULTIDRUG-RESISTANT TUBERCULOSIS PATHOGENESIS CORPORATION (US) 2000-07-11 US disclosed
EP-0866793-A4 1998-10-07 EP disclosed
EP-0866793-A1 NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF PATHOGENESIS CORPORATION (US) 1998-09-30 EP disclosed
WO-1997001562-A1 NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF PATHOGENESIS CORPORATION (US) 1997-01-16 WO disclosed